Testosterone Heart Attack
Men who use AndroGel and other low-T therapies may be in danger of suffering a testosterone-related heart attack or stroke, according to recent warnings from federal health regulators. In May 2015, the U.S. Food & Drug Administration (FDA) required the manufacturers of all prescription testosterone treatments to add new warnings to their labels regarding these potential risks.
Testosterone Lawsuit Reviews
Thousands of men have filed testosterone lawsuits in order to obtain compensation for heart attacks, strokes and other cardiovascular complications allegedly associated with the use of low-T therapy. If you or a man you love experienced a serious heart problem while using AndroGel or another testosterone replacement drug, please call (888) 994-5118 to arrange for a free, no-obligation case review with the legal team at Bernstein Liebhard LLP.
What is Low-T Therapy?
Testosterone replacement therapy was originally intended to treat men who suffer from hypogonadism (low testosterone) as a result of an associated medical condition. Drugs in this class include a number of gels, injections, or patches, including:
Even though these drugs are not approved to treat age-related hypogonadism, a growing number of testosterone lawsuits claim that their manufacturers marketed the products for this very purpose. They further allege that these marketing tactics positioned low-T therapies as remedies for low sex drive, weaker bone density, diminishing muscle mass, and other age-related symptoms. As a result, many men who used the medications had no medical reason to do so.
FDA Testosterone Warnings
In January 2014, the FDA announced it was investigating the potential for testosterone –related heart attacks, strokes and sudden death among men who used low-T therapies. The FDA’s concern was prompted by two studies that suggested these medications might raise heart risks in certain men:
- November 2013: Research published in JAMA suggested a 30 percent increased risk of stroke, heart attack, and death in older men that had been prescribed testosterone therapy.
- January 2014: A second study that appeared in PLoS One in January reported a two-fold increase in the risk of heart attack among men aged 65 years and older within the first 90 days of their first testosterone therapy prescription. Men under 65 with a pre-existing history of heart disease had a two- to three-fold increased risk of testosterone heart attack within the first 90 days.
The FDA completed its review in March 2015, and ordered low-T manufacturers to add new warnings to their product labels regarding a possible association with heart attacks and strokes. The FDA also required that the labeling be modified to clearly state that the drugs hadn’t been proven safe or effective in treating age-related hypogonadism. Read More
Testosterone Lawsuit News
Since the FDA issued its alert, thousands of men have filed lawsuits after suffering heart attacks and other cardiovascular problems that were allegedly caused by AndroGel and other low T therapies.
- June 2014: Federal testosterone lawsuits filed on behalf of men who allegedly suffered heart attacks, strokes and blood clots due to their use of AndroGel and other low-T therapies are centralized in the U.S. District Court, Northern District of Illinois. Read More
- April 2014: Plaintiffs who have filed AndroGel lawsuits and other testosterone claims over the drugs’ alleged cardiovascular side effects seek the creation of a multidistrict litigation for all federal claims in a single U.S. District Court. Read More
Are You Eligible to File a Testosterone Heart Attack Lawsuit?
There is still time for the alleged victims of testosterone-related heart attacks to file their own lawsuits against the manufacturers of low-T therapies. To learn more about this growing litigation, please contact our attorneys today, by calling (888) 994-5118.
- FDA (2014) “FDA Drug Safety Communication: FDA evaluating risk of stroke, heart attack and death with FDA-approved testosterone products” http://www.fda.gov/Drugs/DrugSafety/ucm383904.htm
- JAMA (2013) “Association of Testosterone Therapy With Mortality, Myocardial Infarction, and Stroke in Men With Low Testosterone Levels” http://jama.jamanetwork.com/article.aspx?articleid=1764051
- PLoS One (2014) “Increased Risk of Non-Fatal Myocardial Infarction Following Testosterone Therapy Prescription in Men” http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0085805
- FDA (2015) “FDA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke with use” http://www.fda.gov/Drugs/DrugSafety/ucm436259.htm
Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.
Follow Us
